# The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023, Regulation 103: Amendment of the National Health Service (Pharmaceutical Services) (Wales) Regulations 2020 (English language text)

Extent: E+W+S+N.I.

(1) The English language text of the National Health Service (Pharmaceutical Services) (Wales) Regulations 2020 is amended as follows.
(2) In regulation 2, in paragraph (1) in the definition of “equivalent body” for “the National Health Service Commissioning Board” substitute “NHS England”.
(3) In regulation 42, in paragraph (2)(h) for “the National Health Service Commissioning Board” substitute “NHS England”.
(4) In Schedule 5, in paragraph 28(3)(c)(iv) for “the National Health Service Commissioning Board” substitute “NHS England”.
(5) In Schedule 6, in paragraph 17(3)(c)(iv) for “the National Health Service Commissioning Board” substitute “NHS England”.

---
Source: https://www.legislation.gov.uk/uksi/2023/1071/regulation/103 (the official version)
Page: https://openlegislation.uk/health-and-care-act-2022-further-consequential-amendments-no-2-regulations-2023/regulation-103
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

